Patent · US Active

Solvent cast film sustained release latanoprost implant

US8715713B2 · kind B2 · utility

2Cited by
45References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2012
Grant dateMay 6, 2014
Priority date
Expiry dateApr 27, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a sustained release latanoprost implant in the form of a thin film comprising latanoprost incorporated in a biodegradable polymer matrix. Preferably, said implant is an intraocular implant comprising a thin film comprising latanoprost incorporated in a biodegradable polymer matrix wherein said implant is configured as a disc or a rolled film that can be inserted into the eye and unrolls to provide a film having a high surface area to volume ratio.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.